BWX Technologies, Inc. (BMV:BWXT)
Mexico · Delayed Price · Currency is MXN 2,035.00
0.00 (0.00%)
At close: Aug 8, 2025, 2:00 PM CST
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 294.35 | 281.94 | 245.85 | 238.19 | 305.87 | 278.67 | Upgrade |
Depreciation & Amortization | 94.87 | 85.86 | 78.57 | 73.84 | 69.08 | 60.67 | Upgrade |
Loss (Gain) From Sale of Assets | -0.02 | 4.39 | 1.03 | 5.52 | - | - | Upgrade |
Loss (Gain) on Equity Investments | -10 | -10.6 | 11.13 | -3.46 | -13.02 | -2.15 | Upgrade |
Stock-Based Compensation | 25.14 | 21.68 | 15.9 | 14.13 | 18.61 | 16.84 | Upgrade |
Other Operating Activities | 24.89 | 34.27 | 27.9 | 57.99 | 20.23 | 17.17 | Upgrade |
Change in Accounts Receivable | 51.6 | -54.73 | 29.33 | -23.45 | 16.87 | -151.54 | Upgrade |
Change in Accounts Payable | -5.61 | 34.53 | -9.03 | -40.5 | 28.8 | -1.24 | Upgrade |
Change in Income Taxes | 30.95 | 1.65 | -4.79 | -0.76 | 4.12 | 1.16 | Upgrade |
Change in Other Net Operating Assets | 13.03 | 9.43 | -32.19 | -76.8 | -64.52 | -23.14 | Upgrade |
Operating Cash Flow | 519.2 | 408.43 | 363.7 | 244.7 | 386.03 | 196.44 | Upgrade |
Operating Cash Flow Growth | 31.43% | 12.30% | 48.63% | -36.61% | 96.51% | -29.68% | Upgrade |
Capital Expenditures | -158.92 | -153.65 | -151.29 | -198.31 | -311.05 | -255.03 | Upgrade |
Cash Acquisitions | -538.18 | - | - | -47.33 | - | -15.91 | Upgrade |
Investment in Securities | -29.8 | -0.2 | 3.65 | -11.44 | 0.81 | 2.22 | Upgrade |
Other Investing Activities | 3.49 | -0.72 | -8.01 | 0.84 | 5.59 | 3.4 | Upgrade |
Investing Cash Flow | -723.42 | -154.56 | -155.64 | -256.24 | -304.65 | -265.32 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 88.69 | Upgrade |
Long-Term Debt Issued | - | 456 | 353.1 | 978.2 | 1,324 | 844.5 | Upgrade |
Total Debt Issued | 973 | 456 | 353.1 | 978.2 | 1,324 | 933.19 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -88.69 | - | Upgrade |
Long-Term Debt Repaid | - | -612.25 | -434.35 | -878.2 | -999.3 | -794.68 | Upgrade |
Total Debt Repaid | -657.38 | -612.25 | -434.35 | -878.2 | -1,088 | -794.68 | Upgrade |
Net Debt Issued (Repaid) | 315.63 | -156.25 | -81.25 | 100 | 236.31 | 138.52 | Upgrade |
Repurchase of Common Stock | -43.51 | -27.57 | -7.59 | -26.59 | -230.83 | -27.21 | Upgrade |
Common Dividends Paid | -90.77 | -88.35 | -84.97 | -81.07 | -79.67 | -72.94 | Upgrade |
Other Financing Activities | 16.71 | 19.38 | 4.45 | 21.61 | -15.95 | -13.32 | Upgrade |
Financing Cash Flow | 198.05 | -252.79 | -169.37 | 13.95 | -90.14 | 25.05 | Upgrade |
Foreign Exchange Rate Adjustments | -4.29 | -2.13 | 1.94 | -1.21 | 0.24 | -0.27 | Upgrade |
Net Cash Flow | -10.46 | -1.04 | 40.63 | 1.22 | -8.52 | -44.1 | Upgrade |
Free Cash Flow | 360.28 | 254.78 | 212.42 | 46.39 | 74.97 | -58.59 | Upgrade |
Free Cash Flow Growth | 42.69% | 19.95% | 357.87% | -38.12% | - | - | Upgrade |
Free Cash Flow Margin | 12.58% | 9.42% | 8.51% | 2.08% | 3.53% | -2.76% | Upgrade |
Free Cash Flow Per Share | 3.92 | 2.77 | 2.31 | 0.51 | 0.79 | -0.61 | Upgrade |
Cash Interest Paid | 70.28 | 72.43 | 63.22 | 51.34 | 50.84 | 38.27 | Upgrade |
Cash Income Tax Paid | 12.02 | 45.51 | 84.48 | 71.76 | 44.95 | 73.59 | Upgrade |
Levered Free Cash Flow | 217.08 | 110.75 | 107.05 | -32.07 | 15.23 | -109.72 | Upgrade |
Unlevered Free Cash Flow | 241.41 | 135.42 | 136.45 | -9.31 | 37.58 | -90.34 | Upgrade |
Change in Working Capital | 89.97 | -9.11 | -16.68 | -141.5 | -14.74 | -174.77 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.